Theranostics

Papers
(The H4-Index of Theranostics is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Engineering exosomes for targeted drug delivery547
Turning cold tumors into hot tumors by improving T-cell infiltration306
Immunopathogenesis and treatment of cytokine storm in COVID-19301
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance287
The double-edged roles of ROS in cancer prevention and therapy254
Ferroptosis as a novel therapeutic target for cardiovascular disease240
Platinum-based drugs for cancer therapy and anti-tumor strategies201
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer198
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing195
Selective autophagy of intracellular organelles: Recent research advances194
Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications175
Recent progress in nanomedicine for enhanced cancer chemotherapy173
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment172
Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells159
Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors147
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy144
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages140
m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer139
Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control129
Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury116
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes112
An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment104
Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view104
Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia103
Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects102
Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota102
Recent advances in innovative strategies for enhanced cancer photodynamic therapy100
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy100
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR97
IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression97
Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions97
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming96
Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP2892
ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF188
Role of prostaglandin E2 in tissue repair and regeneration88
Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer87
Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I87
Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies87
Pyroptosis in inflammatory diseases and cancer86
M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic stroke in mice85
Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer84
Glioma stem cells and their roles within the hypoxic tumor microenvironment83
Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM282
N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization82
tRNA-derived fragments: Mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections82
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer81
Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer81
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle81
A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models81
Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL1780
Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model80
Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction80
Targeting iron metabolism in cancer therapy78
Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer78
Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B77
Exosome-inflammasome crosstalk and their roles in inflammatory responses77
Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer76
Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation76
Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles74
SERS Tags for Biomedical Detection and Bioimaging74
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images72
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma72
Electroacupuncture ameliorates intestinal inflammation by activating α7nAChR-mediated JAK2/STAT3 signaling pathway in postoperative ileus71
Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria70
Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma69
AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages68
A skeleton muscle model using GelMA-based cell-aligned bioink processed with an electric-field assisted 3D/4D bioprinting68
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy67
Endothelial cell infection and dysfunction, immune activation in severe COVID-1967
Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment67
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy67
0.060147047042847